Factors affecting minority enrollment in Parkinson's disease genetic testing

Sarah Marmol(University of Miami), Jason Margolesky(University of Miami), Lucila Hernández(University of Miami), Danielle S. Shpiner(University of Miami), Silvia Vargas(University of Miami), Taylor Peabody(University of Miami), Matthew Feldman(University of Miami), Carlos Singer(University of Miami Health System), Claudia Cano(University of Miami), Henry Moore(University of Miami), Ihtsham Haq(University of Miami), Corneliu Luca(University of Miami Health System)
Parkinsonism & Related Disorders
June 15, 2024
10.1016/j.parkreldis.2024.107040
Cited by 0

Related Papers

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease
|JAMA|2016|397
Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder
|Sleep Medicine|2013|391
Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group
|Sleep Medicine|2013|238
Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study
|The Lancet Neurology|2020|155
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
|Neurology|2016|137